These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 15231047

  • 1. Pharmacokinetic modulation of irinotecan metabolites by sulphobromophthalein in rats.
    Itoh T, Itagaki S, Sasaki K, Hirano T, Takemoto I, Iseki K.
    J Pharm Pharmacol; 2004 Jun; 56(6):809-12. PubMed ID: 15231047
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Biliary excretion of irinotecan and its metabolites.
    Itoh T, Takemoto I, Itagaki S, Sasaki K, Hirano T, Iseki K.
    J Pharm Pharm Sci; 2004 Jan 23; 7(1):13-8. PubMed ID: 15144730
    [Abstract] [Full Text] [Related]

  • 5. Loperamide inhibits the biliary excretion of irinotecan (CPT-11) in the rat isolated perfused liver.
    Tobin PJ, Hong Y, Seale JP, Rivory LP, McLachlan AJ.
    J Pharm Pharmacol; 2005 Jan 23; 57(1):39-45. PubMed ID: 15638991
    [Abstract] [Full Text] [Related]

  • 6. Co-administration of irinotecan decreases the plasma concentration of an active metabolite of amrubicin, amrubicinol in rats.
    Maeda Y, Hamada A, Sanematsu E, Sasaki JI, Yokoo K, Hira A, Saito H.
    Cancer Chemother Pharmacol; 2010 Apr 23; 65(5):953-9. PubMed ID: 19697031
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Identification and kinetics of a beta-glucuronide metabolite of SN-38 in human plasma after administration of the camptothecin derivative irinotecan.
    Rivory LP, Robert J.
    Cancer Chemother Pharmacol; 1995 Apr 23; 36(2):176-9. PubMed ID: 7767955
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics, metabolism, and excretion of irinotecan (CPT-11) following I.V. infusion of [(14)C]CPT-11 in cancer patients.
    Slatter JG, Schaaf LJ, Sams JP, Feenstra KL, Johnson MG, Bombardt PA, Cathcart KS, Verburg MT, Pearson LK, Compton LD, Miller LL, Baker DS, Pesheck CV, Lord RS.
    Drug Metab Dispos; 2000 Apr 23; 28(4):423-33. PubMed ID: 10725311
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Involvement of up-regulation of hepatic breast cancer resistance protein in decreased plasma concentration of 7-ethyl-10-hydroxycamptothecin (SN-38) by coadministration of S-1 in rats.
    Yokoo K, Hamada A, Watanabe H, Matsuzaki T, Imai T, Fujimoto H, Masa K, Imai T, Saito H.
    Drug Metab Dispos; 2007 Sep 23; 35(9):1511-7. PubMed ID: 17537871
    [Abstract] [Full Text] [Related]

  • 14. A mechanistic study on altered pharmacokinetics of irinotecan by St. John's wort.
    Hu ZP, Yang XX, Chen X, Cao J, Chan E, Duan W, Huang M, Yu XQ, Wen JY, Zhou SF.
    Curr Drug Metab; 2007 Feb 23; 8(2):157-71. PubMed ID: 17305494
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics of prolonged-release CPT-11-loaded microspheres in rats.
    Machida Y, Onishi H, Kurita A, Hata H, Morikawa A, Machida Y.
    J Control Release; 2000 May 15; 66(2-3):159-75. PubMed ID: 10742577
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Inhibition of intestinal microflora beta-glucuronidase modifies the distribution of the active metabolite of the antitumor agent, irinotecan hydrochloride (CPT-11) in rats.
    Takasuna K, Hagiwara T, Hirohashi M, Kato M, Nomura M, Nagai E, Yokoi T, Kamataki T.
    Cancer Chemother Pharmacol; 1998 May 15; 42(4):280-6. PubMed ID: 9744772
    [Abstract] [Full Text] [Related]

  • 20. Population pharmacokinetic model for irinotecan and two of its metabolites, SN-38 and SN-38 glucuronide.
    Klein CE, Gupta E, Reid JM, Atherton PJ, Sloan JA, Pitot HC, Ratain MJ, Kastrissios H.
    Clin Pharmacol Ther; 2002 Dec 15; 72(6):638-47. PubMed ID: 12496745
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.